Friday, December 4, 2020

Tag: Biotechnology

Emerging Growth Biotechnology Stocks

Cannabics Pharmaceuticals (CNBX) receives “Intention to Grant a European Patent”

Cannabics Pharmaceuticals (CNBX) receives "Intention to Grant a European Patent"

Tonix Pharmaceuticals (TNXP) Could Be a Come-From-Behind Vaccine Shocker

Among small-capitalization companies in the Covid-19 race, Tonix Pharmaceuticals (NASDAQ:TNXP) may be worth consideration with what I would term “dumb money.” Currently, TNXP stock is trading hands for less than a buck, which immediately tells you something about this opportunity’s risk profile.

A low float Biotech that’s ahead of the Curve; Focus on...

Back in July, the stock was given a target price of between $1.74 and $2.32 per share by Marble Arch Research. You can download the full report here: - Among other results, the report states “At ~1x FY23 sales, the stock is substantially undervalued relative to its comps mostly trading in a comparable 3X-4X P/S multiple range.”

BioLife Sciences (BLFE) Announces Immediate Commercial Availability of a 10-Minute, Ultra-Rapid,...

Miami, FL – October 26, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging...

Can B’s (CANB) Director and CFO, Stanley Teeple, to Update on...

In the podcast, Mr. Teeple will discuss the current state of Can B Corp, along with its subsidiaries, new product launches, its FDA approved medical device and its strong medical advisory team.

A niche company in biotech could prove to be the biggest...

Recently trading at around .70 per share, PetVivo Holdings, Inc. (OTCQB: PETV) just announced something interesting on Tuesday which brought a $1.40 share price and what could be the beginning of a strong accumulation of their stock.

Can B Corp. (OTCQB: CANB) Partners with Dr. Karl Zarse to...

Miami, FL –October 22, 2020, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for...

Stocks to Own in October

The writer also likes Facebook (NYSE: FB) citing the stock is cheap, being around 14% below its august highs. But with the largest hater of tech, (Elizabeth Warren) potentially coming into some great power if Biden should pull out a win, I would stay cautiously away from big tech as her plans could include break up’s of companies like FB.

Cannabics Pharmaceuticals (CNBX) Prepares to Submit the FDA with a pre-IND...

Cannabics Pharmaceuticals (CNBX) Prepares to Submit the FDA with a pre-IND Meeting Request for its Proprietary Colon Cancer Drug Candidate, CANNABICS™ RCC-33

Stocks that are most Vulnerable to a Biden Victory

Glucose Health, Inc. (OTC Pink: GLUC) just announced unprecedented consumer demand and 2nd quarter fiscal 2020 sales. 2nd quarter fiscal 2020 revenues increased 186% compared to the 2nd quarter of fiscal 2019 – in fact, Q2 2020 revenues were just $7,140 short of tripling 2nd quarter 2019 revenues.